Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.034
Handel nachbörslich:
.05
0.05
+
Schlusskurs vom Vortag:
$0.034
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.74M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
0.00
EPS:
-6
Netto-Cashflow:
$-43.02M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.00 | 3.74M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
Is Accelerate Diagnostics Inc. stock poised for growthPortfolio Gains Report & Daily Technical Forecast Reports - Newser
How to use Fibonacci retracement on Accelerate Diagnostics Inc.2025 Price Momentum & Short-Term Trading Alerts - Newser
Accelerate Diagnostics Inc.’s volatility index tracking explainedJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Will Accelerate Diagnostics Inc. continue its uptrendJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
What’s next for Accelerate Diagnostics Inc. stock priceEarnings Growth Summary & Free Verified High Yield Trade Plans - Newser
Sentiment analysis tools applied to Accelerate Diagnostics Inc.2025 Key Lessons & Detailed Earnings Play Alerts - Newser
Technical analysis overview for Accelerate Diagnostics Inc. stockJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Analyzing Accelerate Diagnostics Inc. with risk reward ratio chartsWeekly Gains Report & Accurate Entry/Exit Alerts - Newser
Will Accelerate Diagnostics Inc. price bounce be sustainable2025 Support & Resistance & Short-Term High Return Ideas - Newser
Price momentum metrics for Accelerate Diagnostics Inc. explainedTrade Volume Report & Daily Market Momentum Tracking - Newser
How to build a custom watchlist for Accelerate Diagnostics Inc.2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Market reaction to Accelerate Diagnostics Inc.’s recent newsBond Market & Real-Time Stock Movement Alerts - Newser
Accelerate Diagnostics to sell certain assets, liabilities to Indaba Capital - Medical Buyer
How to track smart money flows in Accelerate Diagnostics Inc.Trade Analysis Report & Low Drawdown Investment Strategies - Newser
Heatmap analysis for Accelerate Diagnostics Inc. and competitorsJuly 2025 Sector Moves & Daily Volume Surge Signals - Newser
Technical signs of recovery in Accelerate Diagnostics Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - Newser
Using R and stats models for Accelerate Diagnostics Inc. forecasting2025 Technical Patterns & Safe Capital Preservation Plans - Newser
Accelerate Diagnostics Delays Q2 2025 Report - MSN
Using RSI to spot recovery in Accelerate Diagnostics Inc.2025 Earnings Surprises & Safe Entry Momentum Tips - Newser
Published on: 2025-08-19 07:16:01 - Newser
How to forecast Accelerate Diagnostics Inc. trends using time seriesTrade Volume Report & Real-Time Sentiment Analysis - Newser
Visualizing Accelerate Diagnostics Inc. stock with heatmapsRecession Risk & Weekly High Potential Alerts - Newser
Accelerate Diagnostics completes asset sale and moves toward liquidation plan - Investing.com Nigeria
Accelerate Diagnostics Liquidation Plan Confirmed by Court - TipRanks
Tools to assess Accelerate Diagnostics Inc.’s risk profilePrice Action & Risk Managed Investment Signals - Newser
Is Accelerate Diagnostics Inc. stock bottoming out2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
What technical models suggest about Accelerate Diagnostics Inc.’s comebackRate Hike & Verified Momentum Stock Watchlist - Newser
What does recent volatility data suggest for Accelerate Diagnostics Inc.Portfolio Growth Summary & Technical Entry and Exit Alerts - Newser
Real time breakdown of Stardust Power Inc. stock performance2025 Macro Impact & AI Enhanced Trading Alerts - Newser
What makes Accelerate Diagnostics Inc. stock price move sharply2025 Trade Ideas & Free Accurate Trade Setup Notifications - Newser
Sector ETF performance correlation with Accelerate Diagnostics Inc.2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Can W. R. Berkley Corporation hit a new high this month2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Applying sector rotation models to Accelerate Diagnostics Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
Watch for Trend Continuation in Accelerate Diagnostics Inc. Next Week2025 Biggest Moves & Safe Entry Trade Signal Reports - newsyoung.net
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):